Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Radius Health (RDUS)

19.19   0.52 (2.79%) 03-03 16:23
Open: 18.54 Pre. Close: 18.67
High: 20.29 Low: 18.2188
Volume: 1,083,853 Market Cap: 900M
Radius Health, Inc., a biopharmaceutical company, develops and commercializes endocrine therapeutics in the areas of osteoporosis and oncology. The company markets TYMLOS, an anabolic agent for the treatment of postmenopausal women with osteoporosis. It is also developing abaloparatide-SC, which is in phase 3 clinical study for the treatment of osteoporosis in men; abaloparatide transdermal patch, a short-wear-time patch, that is in phase 3 clinical study to treat postmenopausal women with osteoporosis; Elacestrant (RAD1901), a selective estrogen receptor degrader, which is in phase 3 clinical study for the treatment of hormone receptor-positive breast cancer; and RAD140, a non-steroidal selective androgen receptor modulator, which is in phase 1A clinical study to treat metastatic breast cancer. The company has collaborations and license agreements with 3M Company; Ipsen Pharma SAS; Eisai Co. Ltd.; Duke University; Guardant Health, Inc.; and Teijin Limited. Radius Health, Inc. was founded in 2003 and is headquartered in Waltham, Massachusetts.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 19.024 - 19.117 19.117 - 19.208
Low: 18.159 - 18.274 18.274 - 18.388
Close: 18.455 - 18.639 18.639 - 18.821

Technical analysis

as of: 2021-03-03 4:08:39 PM
Overall:       
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 25.07     One year: 27.85
Support: Support1: 17.63    Support2: 14.67
Resistance: Resistance1: 21.47    Resistance2: 23.84
Pivot: 19.25
Moving Average: MA(5): 18.92     MA(20): 20.08
MA(100): 17.42     MA(250): 14.84
MACD: MACD(12,26): -0.40     Signal(9): -0.30
Stochastic oscillator: %K(14,3): 23.36     %D(3): 20.42
RSI: RSI(14): 47.82
52-week: High: 23.84  Low: 10.15  Change(%):
Average Vol(K): 3-Month: 46555  10-Days: 46030

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
RDUS has closed below upper band by 47.1%. Bollinger Bands are 30.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Wed, 03 Mar 2021
Radius Health, Inc. Announces $175 Million Financing Transaction - GlobeNewswire

Thu, 25 Feb 2021
Radius Health (RDUS) Q4 2020 Earnings Call Transcript - Motley Fool

Thu, 25 Feb 2021
Radius Health: 4Q Earnings Snapshot - Houston Chronicle

Tue, 23 Feb 2021
When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable? - Simply Wall St

Thu, 18 Feb 2021
Radius Health, Inc. (NASDAQ:RDUS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Thu, 18 Feb 2021
Will Radius Health (RDUS) Report Negative Earnings Next Week? What You Should Know - Nasdaq

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 47
Shares Float (M) 46
% Held by Insiders 0.20
% Held by Institutions 105.91
Shares Short (K) 5,910
Shares Short P. Month (K) 7,070

Stock Financials

EPS -2.430
EPS Est This Year -5.410
EPS Est Next Year -3.920
Book Value (p.s.) -2.330
Profit Margin -48.61
Operating Margin -37.80
Return on Assets (ttm) -25.8
Return on Equity (ttm)
Qtrly Rev. Growth 66.4
Gross Profit (p.s.) 3.395
Sales Per Share 4.974
EBITDA (p.s.) -1.834
Qtrly Earnings Growth
Operating Cash Flow (M) -54
Levered Free Cash Flow (M) -14

Stock Valuations

PE Ratio -7.96
PEG Ratio
Price to Book value -8.30
Price to Sales 3.89
Price to Cash Flow -16.67

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.